Global Periodontal Therapeutics Market - 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,350	195 Pages	DataM Intelligence 4Market Research LLP	May, 2023	DTAM17920870

Best Price Guarantee
Price	from $4,350
Length	195 Pages
Publisher	DataM Intelligence 4Market Research LLP
Published Date	May, 2023
SKU	DTAM17920870

Global Periodontal Therapeutics Market - 2023-2030

The global periodontal therapeutics market reached US$ 734.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 61,459.3 million by 2030. The periodontal therapeutics market is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030). Adjuvant therapies following the use of antibiotics will support the trend in this market.

The non-surgical treatment procedures for gum disease include the use of antibacterial products and deep cleaning of the mouth which is proven to be sufficient for reversing the periodontal disease in its early stages. Antibiotics including both topical and oral are prescribed for the control of inflammation and plaque of the gum tissue. Oral antibiotics are placed in the gaps formed between gums and teeth by microbial infection, commonly called periodontal pockets.

Periodontal diseases can range from mild to severe and can cause tooth loss if left untreated. The major factors for growth of the global periodontal therapeutics market are the increasing awareness of the importance of oral health, the aging population, and the development of new products and technologies.

Market Dynamics

The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period

Oral hygiene has become one of the most important parameters for staying healthy. Therefore, the growing awareness about oral hygiene is driving the periodontal therapeutics market, specifically in developed countries. The World Health Organization (WHO) states that over 530 million children suffer from dental caries of primary teeth.

Key players such as Procter & Gamble and Colgate-Palmolive Company have undertaken initiatives to spread awareness regarding dental hygiene, both for children and adults, creating demand for periodontal therapeutic drugs. Owing to rising awareness for better oral hygiene, the global periodontal therapeutics market will upscale at a rapid pace over the forecast period.

The clinical inefficiencies of antibiotics to hamper periodontal therapeutics market growth.

The partial inefficiency of antibiotics in the treatment of periodontal disease is a key factor limiting the growth of the periodontal therapeutics market. The use of antibiotics in the treatment of gum disease is limited, especially in the later stages of severe periodontitis owing to the low efficiency of treating bacterial infection and healing pockets.

Antibiotic treatment is mostly used in combination with oral surgery or dental cleaning procedures. Furthermore, the overuse and misuse of antibiotics in disease treatment may result in antimicrobial resistance. These factors are expected to hamper the periodontal therapeutics market growth over the forecast period.

COVID-19 Impact Analysis

The global periodontal therapeutics market has experienced a downturn due to the outbreak of COVID-19. In the first half of 2020, there was a slight decrease in the sales growth of antibiotics used for the treatment of periodontal disease. This can be attributed to a reduction in hospital visits for dental services and a decrease in prescriptions from dentists around the world.

Russia Ukraine Conflict Analysis

The global periodontal therapeutic market may be indirectly affected by the ongoing conflict between Russia and Ukraine. Economic sanctions imposed on Russia by several countries due to the conflict have led to repercussions in the Russian economy. As a result, the dental healthcare industry, including the periodontal therapeutic market, may be impacted.

The supply of dental equipment from Russia to other countries may be disrupted due to the war, as Russia both imports and exports dental equipment. Additionally, major pharmaceutical companies such as Pfizer, Bayer, and Sanofi have deferred new investments or developments in Russia, which has led to disruptions in the medicine supply chain. These disruptions caused by the conflict have had a negative impact on the global periodontal therapeutics market.

For more details on this report - Request For Sample

Segment Analysis

The global periodontal therapeutics market is segmented based on treatment, disease type, distribution channel, and region.

Gingivitis segment to hold the highest global periodontal therapeutics market share

The gingivitis segment is expected to dominate and account for 54.7% of the global periodontal therapeutics market share over the forecast period. Gingivitis is one of the most common types of periodontitis. This is usually caused by poor oral hygiene and red, swollen gums. They also tend to bleed easily.

The treatment of gingivitis focuses on reducing inflammation, removing plaque, and establishing good oral hygiene habits to prevent plaque build-up. Mouthwash, topical antibiotics, or antiseptics may be recommended. For more serious infections or periodontitis, the dentist may recommend oral antibiotics. For instance, over-the-counter medicated toothpaste, mouth rinses, and mouth sprays are very safe, provided they are used as directed. Therefore, this segment growth will boost the global periodontal therapeutics market growth over the forecast period.

Geographical Analysis

The presence of major players to dominate the North America region.

North America is expected to have a dominant global periodontal therapeutics market share of around 1/3rd of this market. The U.S. is the largest revenue contributor in North America, and the presence of a large dental workforce in this region indicates its dominance in the global market. For instance, according to the American Dental Association, as of 2022, there are 202,536 professionally active dentists in the U.S. There are 60.8 dentists per 100,000 U.S. population.

Competitive Landscape

The major global players in the market include Kaken Pharmaceutical Co. Ltd., Bausch Health, Colgate-Palmolive, Medicom, Pfizer Inc., 3M, Den-Mat Holdings, LLC, Dentsply Sirona, Xttrium Laboratories, Inc., and Dexcel Pharma.

Why Purchase the Report?
• To visualize the global periodontal therapeutics- market segmentation based on treatment, disease type, distribution channel, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global periodontal therapeutics market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global periodontal therapeutics market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

1. Methodology and Scope: 1.1. Research Methodology; 1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary: 3.1. Snippet by Treatment; 3.2. Snippet by Disease Type; 3.3. Snippet by Distribution Channel; 3.4. Snippet by Region
4. Dynamics: 4.1. Impacting Factors; 4.1.1. Drivers; 4.1.1.1. The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period; 4.1.2. Restraints; 4.1.2.1. The clinical inefficiencies of antibiotics to hamper periodontal therapeutics market growth; 4.1.3. Opportunity; 4.1.4. Impact Analysis
5. Industry Analysis: 5.1. Porter's Five Forces Analysis; 5.2. Supply Chain Analysis; 5.3. Pricing Analysis; 5.4. Regulatory Analysis
6. COVID-19 Analysis: 6.1. Analysis of COVID-19; 6.1.1. Before COVID-19 Scenario; 6.1.2. Present COVID-19 Scenario; 6.1.3. Post COVID-19 or Future Scenario; 6.2. Pricing Dynamics Amid COVID-19; 6.3. Demand-Supply Spectrum; 6.4. Government Initiatives Related to the Market During the Pandemic; 6.5. Manufacturer’s Strategic Initiatives; 6.6. Conclusion
7. By Treatment: 7.1. Introduction; 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment; 7.1.2. Market Attractiveness Index, By Treatment; 7.2. Systemic Antibiotics; 7.2.1. Introduction; 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 7.3. Local Antibiotics
8. By Disease Type: 8.1. Introduction; 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type; 8.1.2. Market Attractiveness Index, By Disease Type; 8.2. Gingivitis*; 8.2.1. Introduction; 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 8.3. Chronic Periodontitis; 8.4. Aggressive Periodontitis; 8.5. Necrotizing Periodontal Disease; 8.6. Others
9. By Distribution Channel: 9.1. Introduction; 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel; 9.1.2. Market Attractiveness Index, By Distribution Channel; 9.2. Retail Pharmacies and Drug Stores*; 9.2.1. Introduction; 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 9.3. Hospital Pharmacies; 9.4. Dental Clinics; 9.5. E-Commerce
10. By Region: 10.1. Introduction; 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region; 10.1.2. Market Attractiveness Index, By Region; 10.2. North America; 10.2.1. Introduction; 10.2.2. Key Region-Specific Dynamics; 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment; 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type; 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel; 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.2.6.1. The U.S.; 10.2.6.2. Canada; 10.2.6.3. Mexico; 10.3. Europe; 10.3.1. Introduction; 10.3.2. Key Region-Specific Dynamics; 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment; 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type; 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel; 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.3.6.1. Germany; 10.3.6.2. The U.K.; 10.3.6.3. France; 10.3.6.4. Italy; 10.3.6.5. Spain; 10.3.6.6. Rest of Europe; 10.4. South America; 10.4.1. Introduction; 10.4.2. Key Region-Specific Dynamics; 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment; 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type; 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel; 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.4.6.1. Brazil; 10.4.6.2. Argentina; 10.4.6.3. Rest of South America; 10.5. Asia-Pacific; 10.5.1. Introduction; 10.5.2. Key Region-Specific Dynamics; 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment; 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type; 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel; 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.5.6.1. China; 10.5.6.2. India; 10.5.6.3. Japan; 10.5.6.4. Australia; 10.5.6.5. Rest of Asia-Pacific; 10.6. Middle East and Africa; 10.6.1. Introduction; 10.6.2. Key Region-Specific Dynamics; 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment; 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type; 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11. Competitive Landscape: 11.1. Competitive Scenario; 11.2. Market Positioning/Share Analysis; 11.3. Mergers and Acquisitions Analysis
12. Company Profiles: 12.1. Kaken Pharmaceutical Co. Ltd.*; 12.1.1. Company Overview; 12.1.2. Product Portfolio and Description; 12.1.3. Financial Overview; 12.1.4. Key Developments; 12.2. Bausch Health; 12.3. Colgate-Palmolive; 12.4. Medicom; 12.5. Pfizer Inc.; 12.6. 3M; 12.7. Den-Mat Holdings, LLC; 12.8. Dentsply Sirona; 12.9. Xttrium Laboratories, Inc.; 12.10. Dexcel Pharma; LIST NOT EXHAUSTIVE
13. Appendix: 13.1. About Us and Services; 13.2. Contact Us